224 related articles for article (PubMed ID: 29460498)
1. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
[TBL] [Abstract][Full Text] [Related]
2. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.
Baine FK; Kay C; Ketelaar ME; Collins JA; Semaka A; Doty CN; Krause A; Greenberg LJ; Hayden MR
Eur J Hum Genet; 2013 Oct; 21(10):1120-7. PubMed ID: 23463025
[TBL] [Abstract][Full Text] [Related]
3. High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.
Semaka A; Kay C; Doty CN; Collins JA; Tam N; Hayden MR
Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):864-71. PubMed ID: 24038799
[TBL] [Abstract][Full Text] [Related]
4. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
[TBL] [Abstract][Full Text] [Related]
5. The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
Kay C; Tirado-Hurtado I; Cornejo-Olivas M; Collins JA; Wright G; Inca-Martinez M; Veliz-Otani D; Ketelaar ME; Slama RA; Ross CJ; Mazzetti P; Hayden MR
Eur J Hum Genet; 2017 Feb; 25(3):332-340. PubMed ID: 28000697
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Huntington disease.
Kay C; Hayden MR; Leavitt BR
Handb Clin Neurol; 2017; 144():31-46. PubMed ID: 28947124
[TBL] [Abstract][Full Text] [Related]
7. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
Apolinário TA; Paiva CL; Agostinho LA
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
[TBL] [Abstract][Full Text] [Related]
8. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
Krause A; Mitchell C; Essop F; Tager S; Temlett J; Stevanin G; Ross C; Rudnicki D; Margolis R
Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):573-85. PubMed ID: 26079385
[TBL] [Abstract][Full Text] [Related]
9. Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population.
Mongelli A; Magri S; Salvatore E; Rizzo E; De Rosa A; Fico T; Gatti M; Gellera C; Taroni F; Mariotti C; Nanetti L
Neurol Sci; 2020 Jun; 41(6):1475-1482. PubMed ID: 31940111
[TBL] [Abstract][Full Text] [Related]
10. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Warby SC; Visscher H; Collins JA; Doty CN; Carter C; Butland SL; Hayden AR; Kanazawa I; Ross CJ; Hayden MR
Eur J Hum Genet; 2011 May; 19(5):561-6. PubMed ID: 21248742
[TBL] [Abstract][Full Text] [Related]
11. Genetic aspects of Huntington's disease in Latin America. A systematic review.
Castilhos RM; Augustin MC; Santos JA; Perandones C; Saraiva-Pereira ML; Jardim LB;
Clin Genet; 2016 Mar; 89(3):295-303. PubMed ID: 26178794
[TBL] [Abstract][Full Text] [Related]
12. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
Kay C; Collins JA; Caron NS; Agostinho LA; Findlay-Black H; Casal L; Sumathipala D; Dissanayake VHW; Cornejo-Olivas M; Baine F; Krause A; Greenberg JL; Paiva CLA; Squitieri F; Hayden MR
Am J Hum Genet; 2019 Dec; 105(6):1112-1125. PubMed ID: 31708117
[TBL] [Abstract][Full Text] [Related]
14. Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.
Almqvist E; Spence N; Nichol K; Andrew SE; Vesa J; Peltonen L; Anvret M; Goto J; Kanazawa I; Goldberg YP
Hum Mol Genet; 1995 Feb; 4(2):207-14. PubMed ID: 7757069
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis and prevalence of Huntington disease in northwestern Iran.
Shekari Khaniani M; Aob P; Ranjouri M; Mansoori Derakhsan S
Turk J Med Sci; 2017 Dec; 47(6):1880-1884. PubMed ID: 29306253
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
[TBL] [Abstract][Full Text] [Related]
17. Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East.
Squitieri F; Mazza T; Maffi S; De Luca A; AlSalmi Q; AlHarasi S; Collins JA; Kay C; Baine-Savanhu F; Landwhermeyer BG; Sabatini U; Hayden MR
Genet Med; 2020 Nov; 22(11):1903-1908. PubMed ID: 32661355
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
Kay C; Collins JA; Skotte NH; Southwell AL; Warby SC; Caron NS; Doty CN; Nguyen B; Griguoli A; Ross CJ; Squitieri F; Hayden MR
Mol Ther; 2015 Nov; 23(11):1759-1771. PubMed ID: 26201449
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population.
Ramírez-García MÁ; Dávila-Ortiz de Montellano DJ; Martínez-Ruano L; Ochoa-Morales A; Romero-Hidalgo S; Zenteno JC; Yescas-Gómez P
Neurodegener Dis; 2022; 22(1):34-42. PubMed ID: 35926480
[TBL] [Abstract][Full Text] [Related]
20. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.
Chong SS; Almqvist E; Telenius H; LaTray L; Nichol K; Bourdelat-Parks B; Goldberg YP; Haddad BR; Richards F; Sillence D; Greenberg CR; Ives E; Van den Engh G; Hughes MR; Hayden MR
Hum Mol Genet; 1997 Feb; 6(2):301-9. PubMed ID: 9063751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
